Back
Fidelity Disruptive Medicine ETF Vs. Tema Obesity & Cardiometabolic ETF Industry Stock Comparison
Sell
43
FMED
Fidelity Disruptive Medicine ETF
Last Price:
25.35
Seasonality Move:
18.25%
Sell
10
HRTS
Tema Obesity & Cardiometabolic ETF
Last Price:
31.29
Seasonality Move:
0%
Sell
43
Fidelity Disruptive Medicine ETF (FMED)
is a Sell
Is Fidelity Disruptive Medicine ETF a Buy, Sell or Hold?
- The current Fidelity Disruptive Medicine ETF [FMED] share price is $25.44. The Score for FMED is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- FMED is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
10
Tema Obesity & Cardiometabolic ETF (HRTS)
is a Sell
Is Tema Obesity & Cardiometabolic ETF a Buy, Sell or Hold?
- The current Tema Obesity & Cardiometabolic ETF [HRTS] share price is $31.33. The Score for HRTS is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
- HRTS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
FMED Stock Price Chart
What is Fidelity Disruptive Medicine ETF's stock price today?
-
The Fidelity Disruptive Medicine ETF share price today is $25.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FMED is experiencing buying pressure, which is a positive indicator for future bullish movement.
HRTS Stock Price Chart
What is Tema Obesity & Cardiometabolic ETF's stock price today?
-
The Tema Obesity & Cardiometabolic ETF share price today is $31.33
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HRTS is experiencing buying pressure, which is a positive indicator for future bullish movement.
FMED Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 46.25 | Sell |
| Chaikin Money Flow: | 3430 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.25 - 26.23) | Sell |
| Bollinger Bands (100): | (24.85 - 26.19) | Sell |
HRTS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.74 | Sell |
| Relative Strength Index (14 RSI): | 38.16 | Sell |
| Chaikin Money Flow: | 7572 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.56 - 33.92) | Sell |
| Bollinger Bands (100): | (32.73 - 34.91) | Sell |
FMED Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.2 | Buy |
| 20-day SMA: | 25.68 | Sell |
| 50-day SMA: | 25.91 | Sell |
| 200-day SMA: | 24.99 | Buy |
| 8-day EMA: | 25.32 | Buy |
| 20-day EMA: | 25.58 | Sell |
| 50-day EMA: | 25.7 | Sell |
| 200-day EMA: | 24.96 | Buy |
HRTS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.25 | Buy |
| 20-day SMA: | 32.52 | Sell |
| 50-day SMA: | 33.31 | Sell |
| 200-day SMA: | 33.28 | Sell |
| 8-day EMA: | 31.39 | Sell |
| 20-day EMA: | 32.22 | Sell |
| 50-day EMA: | 33.02 | Sell |
| 200-day EMA: | 32.73 | Sell |
Fidelity Disruptive Medicine ETF Earnings Growth & FMED Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Tema Obesity & Cardiometabolic ETF Earnings Growth & HRTS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Fidelity Disruptive Medicine ETF Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Tema Obesity & Cardiometabolic ETF Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||